Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wini Zambare

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Surgical Oncology Insight|November 27, 2025
Assessing the OPRA Trial for surgical oncologists: Safety and feasibility of a total neoadjuvant therapy approach in patients with rectal cancerWini Zambare, Joao Miranda, Natally Horvat, et al.
The Laryngoscope|October 1, 2020
Barriers to Voice Therapy Attendance in a Language-Diverse PopulationKah Whye Ryan Lim, Wini Zambare, Batsheva R Rubin, et al.
Journal of the American College of Surgeons|February 28, 2024
Effect of Specimen Extraction Site on Postoperative Incisional Hernia after Minimally Invasive Right ColectomyJosh A Johnson, Andrea Mesiti, Margo Herre, et al.
Translational Oncology|January 4, 2025
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selectionWei Zhang, Chao Wu, Hanchen Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
Enhancing Chemotherapy Response Prediction via Matched Colorectal Tumor-Organoid Gene Expression Analysis and Network-Based Biomarker SelectionWei Zhang, Chao Wu, Hanchen Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Integrating Tumor and Organoid DNA Methylation Profiles Reveals Robust Predictors of Chemotherapy Response in Rectal CancerDavid Lukacsovich, Wini Zambare, Chao Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Discovery of Oncogenic Mediator Genes in Rectal Cancer Chemotherapy Response using Gene Expression Data from Matched Tumor and Patient-Derived OrganoidHanchen Huang, Chao Wu, Antonio Colaprico, et al.
Journal of the National Cancer Institute|March 20, 2025
Utilizing Patient Input in Rectal Cancer Trial DesignJanet Alvarez, Wini Zambare, Manju George, et al.
BMC Cancer|July 26, 2024
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancerJanet A Alvarez, Qian Shi, Arvind Dasari, et al.
Nature Communications|February 26, 2026
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinomaPaul B Romesser, Aron Bercz, Janet Alvarez, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Surgical Oncology Insight|November 27, 2025
Assessing the OPRA Trial for surgical oncologists: Safety and feasibility of a total neoadjuvant therapy approach in patients with rectal cancerWini Zambare, Joao Miranda, Natally Horvat, et al.
The Laryngoscope|October 1, 2020
Barriers to Voice Therapy Attendance in a Language-Diverse PopulationKah Whye Ryan Lim, Wini Zambare, Batsheva R Rubin, et al.
Journal of the American College of Surgeons|February 28, 2024
Effect of Specimen Extraction Site on Postoperative Incisional Hernia after Minimally Invasive Right ColectomyJosh A Johnson, Andrea Mesiti, Margo Herre, et al.
Translational Oncology|January 4, 2025
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selectionWei Zhang, Chao Wu, Hanchen Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
Enhancing Chemotherapy Response Prediction via Matched Colorectal Tumor-Organoid Gene Expression Analysis and Network-Based Biomarker SelectionWei Zhang, Chao Wu, Hanchen Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Integrating Tumor and Organoid DNA Methylation Profiles Reveals Robust Predictors of Chemotherapy Response in Rectal CancerDavid Lukacsovich, Wini Zambare, Chao Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Discovery of Oncogenic Mediator Genes in Rectal Cancer Chemotherapy Response using Gene Expression Data from Matched Tumor and Patient-Derived OrganoidHanchen Huang, Chao Wu, Antonio Colaprico, et al.
Journal of the National Cancer Institute|March 20, 2025
Utilizing Patient Input in Rectal Cancer Trial DesignJanet Alvarez, Wini Zambare, Manju George, et al.
BMC Cancer|July 26, 2024
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancerJanet A Alvarez, Qian Shi, Arvind Dasari, et al.
Nature Communications|February 26, 2026
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinomaPaul B Romesser, Aron Bercz, Janet Alvarez, et al.
Pageof 1